UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics

Clinical and experimental allergy, 2014-08, Vol.44 (8), p.1044-1052

2014

Link zum Volltext

Verfügbarkeit prüfen

Glutathione‐PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first‐in‐human study

British journal of clinical pharmacology, 2018-05, Vol.84 (5), p.1020-1028

2018

Link zum Volltext

Verfügbarkeit prüfen

The use of machine learning improves the assessment of drug-induced driving behaviour

Accident analysis and prevention, 2020-12, Vol.148, p.105822-105822, Article 105822

2020

Link zum Volltext

Verfügbarkeit prüfen

The Perception and Pharmacokinetics of a 20-mg Dose of Escitalopram Orodispersible Tablets in a Relative Bioavailability Study in Healthy Men

Clinical therapeutics, 2011-10, Vol.33 (10), p.1492-1502

2011

Link zum Volltext

Verfügbarkeit prüfen

Using machine learning techniques to characterize sleep-deprived driving behavior

Traffic injury prevention, 2021, Vol.22 (5), p.366-371

2021

Link zum Volltext

Verfügbarkeit prüfen

341 Acute effects of seltorexant, a selective orexin-2 antagonist (JNJ- 42847922), on driving after bedtime administration

Sleep (New York, N.Y.), 2021-05, Vol.44 (Supplement_2), p.A136-A136

2021

Link zum Volltext

Verfügbarkeit prüfen

Positioning functional foods in an ecological approach to the prevention of overweight and obesity

Obesity reviews, 2008-09, Vol.9 (5), p.464-473

2008

Link zum Volltext

Verfügbarkeit prüfen

On the use of the Goodman diagram for high cycle fatigue design

International journal of fracture, 1996-07, Vol.80 (2-3), p.219-235

1996

Link zum Volltext

Verfügbarkeit prüfen

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Journal of psychopharmacology (Oxford), 2019-02, Vol.33 (2), p.202-209

2019

Link zum Volltext

Verfügbarkeit prüfen

0007 Multiple-Ascending-Dose Study Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, And Tolerability

Sleep (New York, N.Y.), 2018-04, Vol.41 (suppl_1), p.A3-A3

2018

Link zum Volltext

Verfügbarkeit prüfen

0008 Night-Time Administration Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Pharmacokinetics, Next-Day Residual Effects, Safety, And Tolerability

Sleep (New York, N.Y.), 2018-04, Vol.41 (suppl_1), p.A3-A3

2018

Link zum Volltext

Verfügbarkeit prüfen

JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

European neuropsychopharmacology, 2017-10, Vol.27, p.S866

2017

Link zum Volltext

Verfügbarkeit prüfen

P.2.f.035 - JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

European neuropsychopharmacology, 2017-10, Vol.27, p.S866-S866

2017

Link zum Volltext

Verfügbarkeit prüfen

P.1.g.029 - The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

European neuropsychopharmacology, 2017-10, Vol.27, p.S655-S656

2017

Link zum Volltext

Verfügbarkeit prüfen

The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

European neuropsychopharmacology, 2017-10, Vol.27, p.S655-S656

2017

Link zum Volltext

Verfügbarkeit prüfen

Setipiprant, a selective CRTH 2 antagonist, reduces allergen‐induced airway responses in allergic asthmatics

Clinical and experimental allergy, 2014-08, Vol.44 (8), p.1044-1052

2014

Link zum Volltext

Verfügbarkeit prüfen

On the analysis of cross-ply laminates with micro-cracks and inelastic deformation

International journal of solids and structures, 1998-01, Vol.35 (1-2), p.107-127

1998

Link zum Volltext

Verfügbarkeit prüfen

Analysis of a pin-loaded viscoplastic plate

Computers & structures, 1995-07, Vol.56 (2), p.295-302

Zuiker, J.R.

1995

Link zum Volltext

Verfügbarkeit prüfen

Functionally graded materials: Choice of micromechanics model and limitations in property variation

Composites engineering, 1995, Vol.5 (7), p.807-819

Zuiker, Joseph R.

1995

Link zum Volltext

Verfügbarkeit prüfen

On the use of the Goodman diagram for high cycle fatigue design : High cycle fatigue

International journal of fracture, 1996, Vol.80 (2-3), p.219-235

1996

Link zum Volltext

Verfügbarkeit prüfen

Appendix I - Computation of High Cycle Fatigue Design Limits under Combined High and Low Cycle Fatigue

High Cycle Fatigue, 2006, p.617-638

Zuiker, Joseph R.

2006

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous measurement of intra-epidermal electric detection thresholds and evoked potentials for observation of nociceptive processing following sleep deprivation

Experimental brain research, 2022-02, Vol.240 (2), p.631-649

2022

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations

British journal of clinical pharmacology, 2022-05, Vol.88 (5), p.2236-2245

2022

Link zum Volltext

Verfügbarkeit prüfen

NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects

Journal of psychopharmacology (Oxford), 2016-03, Vol.30 (3), p.253-262

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(47)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(15)
Technology
(13)
Humans
(11)
Materials Science
(11)
Physics
(10)
Exact Sciences And Technology
(8)
Male
(8)
Adult
(7)
Physical Sciences
(7)
Physics, Applied
(7)
Pharmacology & Pharmacy
(6)
Young Adult
(6)
Drug Dosages
(5)
Female
(5)
Materials Science, Multidisciplinary
(5)
Diamonds
(4)
Engineering
(4)
Middle Aged
(4)
Neurosciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics

Glutathione‐PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first‐in‐human study

The use of machine learning improves the assessment of drug-induced driving behaviour

The Perception and Pharmacokinetics of a 20-mg Dose of Escitalopram Orodispersible Tablets in a Relative Bioavailability Study in Healthy Men

Using machine learning techniques to characterize sleep-deprived driving behavior

341 Acute effects of seltorexant, a selective orexin-2 antagonist (JNJ- 42847922), on driving after bedtime administration

Positioning functional foods in an ecological approach to the prevention of overweight and obesity

On the use of the Goodman diagram for high cycle fatigue design

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

0007 Multiple-Ascending-Dose Study Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, And Tolerability

0008 Night-Time Administration Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Pharmacokinetics, Next-Day Residual Effects, Safety, And Tolerability

JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

P.2.f.035 - JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder

P.1.g.029 - The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

The selective orexin-2 antagonist JNJ-42847922(MIN-202) improves sleep in patients with primary insomnia

Setipiprant, a selective CRTH 2 antagonist, reduces allergen‐induced airway responses in allergic asthmatics

On the analysis of cross-ply laminates with micro-cracks and inelastic deformation

Analysis of a pin-loaded viscoplastic plate

Functionally graded materials: Choice of micromechanics model and limitations in property variation

On the use of the Goodman diagram for high cycle fatigue design : High cycle fatigue

Appendix I - Computation of High Cycle Fatigue Design Limits under Combined High and Low Cycle Fatigue

Simultaneous measurement of intra-epidermal electric detection thresholds and evoked potentials for observation of nociceptive processing following sleep deprivation

Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populations

NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects

Suchergebnisse filtern